AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 75 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 1.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $283,795 | +23.8% | 10,021 | +0.4% | 0.00% | – |
Q1 2023 | $229,241 | -19.0% | 9,980 | -0.9% | 0.00% | – |
Q4 2022 | $282,850 | +23.5% | 10,073 | +24.8% | 0.00% | – |
Q3 2022 | $229,000 | -95.1% | 8,070 | -92.1% | 0.00% | -100.0% |
Q4 2018 | $4,689,000 | +5.9% | 101,700 | +77.2% | 0.00% | +50.0% |
Q3 2018 | $4,427,000 | -8.4% | 57,400 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $4,835,000 | +3.0% | 57,400 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $4,694,000 | +31.4% | 57,400 | -8.2% | 0.00% | 0.0% |
Q4 2017 | $3,573,000 | -17.7% | 62,500 | -3.8% | 0.00% | 0.0% |
Q3 2017 | $4,339,000 | -80.3% | 65,000 | -81.9% | 0.00% | -80.0% |
Q3 2014 | $22,000,000 | +10.0% | 358,600 | -17.8% | 0.01% | +11.1% |
Q2 2014 | $20,000,000 | +6.8% | 436,500 | -8.7% | 0.01% | 0.0% |
Q1 2014 | $18,725,000 | +55.9% | 478,300 | -4.6% | 0.01% | +50.0% |
Q4 2013 | $12,011,000 | -31.7% | 501,500 | -20.3% | 0.01% | -33.3% |
Q3 2013 | $17,598,000 | – | 629,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |